The stock of Medpace Holdings Inc (MEDP) has seen a -13.21% decrease in the past week, with a -8.17% drop in the past month, and a -19.68% decrease in the past quarter. The volatility ratio for the week is 4.30%, and the volatility levels for the past 30 days are at 3.89% for MEDP. The simple moving average for the past 20 days is -6.51% for MEDP’s stock, with a -16.88% simple moving average for the past 200 days.
Is It Worth Investing in Medpace Holdings Inc (NASDAQ: MEDP) Right Now?
Medpace Holdings Inc (NASDAQ: MEDP) has a higher price-to-earnings ratio of 27.57x compared to its average ratio. MEDP has 36-month beta value of 1.37. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 6 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for MEDP is 25.55M, and currently, short sellers hold a 4.30% ratio of that float. The average trading volume of MEDP on November 15, 2024 was 351.28K shares.
MEDP) stock’s latest price update
Medpace Holdings Inc (NASDAQ: MEDP) has seen a decline in its stock price by -5.96 in relation to its previous close of 334.84. However, the company has experienced a -13.21% decline in its stock price over the last five trading sessions. prnewswire.com reported 2024-11-15 that RADNOR, Pa., Nov. 15, 2024 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Medpace Holdings, Inc. (NASDAQ: MEDP) (“Medpace”).
Analysts’ Opinion of MEDP
Many brokerage firms have already submitted their reports for MEDP stocks, with Robert W. Baird repeating the rating for MEDP by listing it as a “Neutral.” The predicted price for MEDP in the upcoming period, according to Robert W. Baird is $349 based on the research report published on October 23, 2024 of the current year 2024.
UBS gave a rating of “Neutral” to MEDP, setting the target price at $350 in the report published on September 27th of the current year.
MEDP Trading at -7.82% from the 50-Day Moving Average
After a stumble in the market that brought MEDP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -31.52% of loss for the given period.
Volatility was left at 3.89%, however, over the last 30 days, the volatility rate increased by 4.30%, as shares sank -11.44% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.99% lower at present.
During the last 5 trading sessions, MEDP fell by -13.00%, which changed the moving average for the period of 200-days by +6.94% in comparison to the 20-day moving average, which settled at $336.83. In addition, Medpace Holdings Inc saw 2.72% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MEDP starting from Kraft Robert O., who sale 4,353 shares at the price of $390.73 back on Aug 22 ’24. After this action, Kraft Robert O. now owns 520 shares of Medpace Holdings Inc, valued at $1,700,848 using the latest closing price.
Kraft Robert O., the Director of Medpace Holdings Inc, sale 3,774 shares at $390.73 during a trade that took place back on Aug 23 ’24, which means that Kraft Robert O. is holding 520 shares at $1,474,615 based on the most recent closing price.
Stock Fundamentals for MEDP
Current profitability levels for the company are sitting at:
- 0.2 for the present operating margin
- 0.29 for the gross margin
The net margin for Medpace Holdings Inc stands at 0.18. The total capital return value is set at 0.39. Equity return is now at value 54.06, with 20.48 for asset returns.
Currently, EBITDA for the company is 363.15 million with net debt to EBITDA at -1.21. When we switch over and look at the enterprise to sales, we see a ratio of 4.51. The receivables turnover for the company is 6.65for trailing twelve months and the total asset turnover is 0.99. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.99.
Conclusion
To put it simply, Medpace Holdings Inc (MEDP) has had a mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
